| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 54 |
| 1 | DEXAMETHASONE 1.5 MG | 54 |
| 2 | CYCLOPHOSPHAMIDE | 52 |
| 3 | CYCLOPHOSPHAMIDE FOR INJECTION | 52 |
| 4 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 52 |
| 5 | RITUXIMAB | 44 |
| 6 | RIBOCICLIB | 41 |
| 7 | LETROZOLE | 38 |
| 8 | LETROZOLE TABLETS | 38 |
| 9 | FULVESTRANT | 32 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | RADIUM RA 223 DICHLORIDE | 14 | 0.0028 |
| 1 | PLERIXAFOR | 4 | 0.0027 |
| 2 | LONCASTUXIMAB TESIRINE | 1 | 0.0024 |
| 3 | TALAZOPARIB | 4 | 0.0022 |
| 4 | CLOFARABINE | 4 | 0.0017 |
| 5 | TALIGLUCERASE ALFA | 1 | 0.0017 |
| 6 | IMIGLUCERASE | 7 | 0.0015 |
| 7 | ISATUXIMAB | 8 | 0.0014 |
| 8 | GRANULOCYTE COLONY STIMULATING FACTOR | 3 | 0.0014 |
| 9 | RIBOCICLIB | 41 | 0.0013 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 86 |
| 1 | Aromatase Inhibitor [EPC] | 62 |
| 2 | Kinase Inhibitor [EPC] | 60 |
| 3 | Alkylating Drug [EPC] | 53 |
| 4 | CD20-directed Cytolytic Antibody [EPC] | 48 |
| 5 | Microtubule Inhibitor [EPC] | 47 |
| 6 | Nucleoside Metabolic Inhibitor [EPC] | 37 |
| 7 | Platinum-based Drug [EPC] | 35 |
| 8 | Estrogen Receptor Antagonist [EPC] | 32 |
| 9 | Thalidomide Analog [EPC] | 32 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Hematopoietic Stem Cell Mobilizer [EPC] | 4 | 0.0027 |
| 1 | CD38-directed Cytolytic Antibody [EPC] | 12 | 0.0021 |
| 2 | Hydrolytic Lysosomal Glucocerebroside-specific Enzyme [EPC] | 9 | 0.0012 |
| 3 | Estrogen Receptor Antagonist [EPC] | 32 | 0.0008 |
| 4 | Aromatase Inhibitor [EPC] | 62 | 0.0005 |
| 5 | Asparagine-specific Enzyme [EPC] | 7 | 0.0005 |
| 6 | HER2/neu Receptor Antagonist [EPC] | 27 | 0.0004 |
| 7 | Glucosylceramide Synthase Inhibitor [EPC] | 1 | 0.0004 |
| 8 | Microtubule Inhibitor [EPC] | 47 | 0.0003 |
| 9 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |